Abstract:Perennial allergic rhinitis (PAR) is an increasing problem for which new and exciting therapies are being developed. A T(H)2-polarized cytokine pattern is thought to predominate regulating local IgE synthesis and cell recruitment in PAR and the development of intranasal steroids has resulted in several agents with quick actions, localized effects and great efficacy in its management. The aim of work was to determine the differences in the local expression of IL-4 and IL-5 in patients with PAR compared to non-atopic healthy controls and investigate the relationship between the expression of these cytokines and the clinical aspects of the disease. Also to evaluate local expression of these cytokines in some of these patients before and after treatment with intranasal steroids (fluticasone proprionate). Nasal biopsies from 37 patients with PAR before therapy and from 8 of them after receiving corticosteroids as local nasal spray were taken. PAR was confirmed by a history of perennial nasal blockage, discharge, and/or sneeze for at least 2 years before the study and by positive skin prick test. Also nasal biopsies were taken from 20 age and gender matched non-atopic controls. Biopsies were analyzed using a reverse transcription-polymerase chain reaction (RT-PCR) to investigate local expression of IL-4 mRNA. Enzyme immunoassay was used for estimation of IL-5 levels in the nasal mucosa. By using the ROC curve; (11 pg/ml) was estimated as a cut-off value for IL-5 where levels below this cut off were considered negative. This study showed that the most common causative allergens in PAR were mite dust, followed by wool & pigeon then mixed moulds. There was a significant relation between expression of IL-4 and IL-5 and the occurrence of allergic rhinitis where mRNA of IL-4 was detected in 17/37 [46%] of patient group and in 3/20 (15%) of the control group (P < 0.05). IL-5 levels were more than the calculated cut off value in 22/37 (59.5%) of patient group as compared to 4/20 (20%) in the control group (P < 0.01). Also a high significant association was found between IL-4 & IL-5 (P < 0.01) in patient group. However, no significant relation was found between signs & symptoms of AR or patients' age or gender and cytokines expression. Corticosteroid nasal spray treatment showed a significant reduction in IL-4 gene expression and IL-5 positivity (P < 0.05). It is concluded that IL-4 & IL-5 have an important role in the pathogenesis of PAR and corticosteroid nasal spray is effective in exerting an immunomodulatory activity by reducing IL-4 & IL-5 expression.

Step-by-step medication regimen in the treatment of perennial allergic rhinitis and its influence on complement C3

[Nasal Coblation Plasma Surgery for the Treatment of Persistent Allergic Rhinitis: an Evaluation of Short-Term Outcomes].

Comparison of clinical characteristics of chronic rhinosinusitis with and without nasal polyps

[Perennial Allergic Rhinitis: Stepwise Regression Analysis on the Correlation with the Efficacy of Allergen-Specific Immunotherapy].

Objective Assessment of Persistent Rhinitis in Chinese and Its Relationship with Serum Indicators

Local expression of IL-4 and IL-5 in perennial allergic rhinitis and their modulation by topical corticosteroid therapy

Effectiveness of intranasal steroids on rhinitis symptoms, sleep quality, and quality of life in patients with perennial allergic rhinitis

Randomized Double-Blind Placebo-Controlled Crossover Study of Efficacy of Pollen Blocker Cream for Perennial Allergic Rhinitis

Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure

Treatment of persistent allergic rhinitis via acupuncture at the sphenopalatine acupoint: a randomized controlled trial

Specific Immunotherapy of Perenial Allergic Rhinitis

Effect of house-dust-mite specific immunotherapy on symptoms and quality of life in patients with perennial allergic rhinitis refractory to common methods

Analysis of the efficacy of azelastine nasal spray combined with mussel mucin in the treatment of allergic rhinitis and the influence of peripheral blood CCL26 and CCR3 levels.

Short-term Efficacy and Factors of Specific Immunotherapy on Patients with Allergic Rhinitis

Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis

Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

[Effects of electroacupuncture on plasma vasoactive intestinal peptide and substance P in perennial allergic rhinitis patients]

Comparison of Intranasal Steroid Application Using Nasal Saline Irrigation and a Mucosal Atomization Device to Treat Chronic Rhinosinusitis

The study of the role of purified anti-mouse CD193 (CCR3) antibody in allergic rhinitis mouse animal models

Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?

Comparison of the Efficacy of Subcutaneous Immunotherapy(scit)and Sublingual Immunotherapy(slit)for Dermatophagoides Pteronyssinus in Patients with Allergic Rhinitis(ar)